✦ LIBER ✦

Bevacizumab Plus Interferon Alfa Compared With Interferon Alfa Monotherapy in Patients With Metastatic Renal Cell Carcinoma: CALGB 90206

✍ Scribed by Kibel, A.S.

Book ID: 122465972
Publisher: Elsevier Science
Year: 2009
Weight: 47 KB
Volume: 2009
Category: Article
ISSN: 0084-4071
DOI: 10.1016/S0084-4071(09)79252-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Radical nephrectomy plus interferon-alfa

Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial

✍ GHJ Mickisch; A Garin; H van Poppel; L de Prijck; R Sylvester 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 85 KB

Overall Survival and Updated Results for

Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

✍ Motzer, R. J.; Hutson, T. E.; Tomczak, P.; Michaelson, M. D.; Bukowski, R. M.; O 📂 Article 📅 2009 🏛 American Society of Clinical Oncology 🌐 English ⚖ 186 KB

Recombinant interferon alfa-2a with or w

Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma

✍ Sophie D. Fossåu; Stephen T. De Garis; Mona S. Heier; Asbjøsrn Flokkmann; Hans H 📂 Article 📅 1986 🏛 John Wiley and Sons 🌐 English ⚖ 552 KB

Bevacizumab plus interferon alfa-2a for

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

✍ Bernard Escudier; Anna Pluzanska; Piotr Koralewski; Alain Ravaud; Sergio Bracard 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 178 KB

Bevacizumab plus interferon alfa-2a for

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

✍ Bernard Escudier; Anna Pluzanska; Piotr Koralewski; Alain Ravaud; Sergio Bracard 📂 Article 📅 2007 🏛 The Lancet 🌐 English ⚖ 178 KB

Bevacizumab plus interferon alfa-2a for

Bevacizumab plus interferon alfa-2a for treatment of metastatic renal cell carcinoma: a randomised, double-blind phase III trial

✍ Coplen, D.E. 📂 Article 📅 2009 🏛 Elsevier Science ⚖ 163 KB